125 related articles for article (PubMed ID: 34622392)
1. Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant.
Laitman Y; Nielsen SM; Hatchell KE; Truty R; Bernstein-Molho R; Esplin ED; Friedman E
Fam Cancer; 2022 Jul; 21(3):305-308. PubMed ID: 34622392
[TBL] [Abstract][Full Text] [Related]
2. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
3. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population.
Shaag A; Walsh T; Renbaum P; Kirchhoff T; Nafa K; Shiovitz S; Mandell JB; Welcsh P; Lee MK; Ellis N; Offit K; Levy-Lahad E; King MC
Hum Mol Genet; 2005 Feb; 14(4):555-63. PubMed ID: 15649950
[TBL] [Abstract][Full Text] [Related]
4. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.
Tischkowitz MD; Yilmaz A; Chen LQ; Karyadi DM; Novak D; Kirchhoff T; Hamel N; Tavtigian SV; Kolb S; Bismar TA; Aloyz R; Nelson PS; Hood L; Narod SA; White KA; Ostrander EA; Isaacs WB; Offit K; Cooney KA; Stanford JL; Foulkes WD
Cancer Lett; 2008 Oct; 270(1):173-80. PubMed ID: 18571837
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women.
Novak DJ; Chen LQ; Ghadirian P; Hamel N; Zhang P; Rossiny V; Cardinal G; Robidoux A; Tonin PN; Rousseau F; Narod SA; Foulkes WD
BMC Cancer; 2008 Aug; 8():239. PubMed ID: 18706089
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.
Leedom TP; LaDuca H; McFarland R; Li S; Dolinsky JS; Chao EC
Cancer Genet; 2016 Sep; 209(9):403-407. PubMed ID: 27751358
[TBL] [Abstract][Full Text] [Related]
8. Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.
Bychkovsky BL; Agaoglu NB; Horton C; Zhou J; Yussuf A; Hemyari P; Richardson ME; Young C; LaDuca H; McGuinness DL; Scheib R; Garber JE; Rana HQ
JAMA Oncol; 2022 Nov; 8(11):1598-1606. PubMed ID: 36136322
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
[TBL] [Abstract][Full Text] [Related]
10. Cancer in Jews: introduction and overview.
Lynch HT; Rubinstein WS; Locker GY
Fam Cancer; 2004; 3(3-4):177-92. PubMed ID: 15516840
[TBL] [Abstract][Full Text] [Related]
11. Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants.
Mundt E; Mabey B; Rainville I; Ricker C; Singh N; Gardiner A; Manley S; Slavin T
Cancer Genet; 2023 Nov; 278-279():84-90. PubMed ID: 37839337
[TBL] [Abstract][Full Text] [Related]
12. Hereditary breast cancer in Jews.
Rubinstein WS
Fam Cancer; 2004; 3(3-4):249-57. PubMed ID: 15516849
[TBL] [Abstract][Full Text] [Related]
13. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations.
Kaufman B; Laitman Y; Gronwald J; Winqvist R; Irmejs A; Lubinski J; Pylkäs K; Gardovskis J; Miklasevics E; Friedman E
Fam Cancer; 2009; 8(4):473-8. PubMed ID: 19609724
[TBL] [Abstract][Full Text] [Related]
15. Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.
Brandt-Rauf SI; Raveis VH; Drummond NF; Conte JA; Rothman SM
Am J Public Health; 2006 Nov; 96(11):1979-88. PubMed ID: 17018815
[TBL] [Abstract][Full Text] [Related]
16. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin.
Baloch AH; Daud S; Raheem N; Luqman M; Ahmad A; Rehman A; Shuja J; Rasheed S; Ali A; Kakar N; Naseeb HK; Mengal MA; Awan MA; Wasim M; Baloch DM; Ahmad J
Mol Biol Rep; 2014 Feb; 41(2):1103-7. PubMed ID: 24390236
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the role of CHEK2 p.(Asp438Tyr) allele in inherited breast cancer predisposition.
Kumpula TA; Koivuluoma S; Soikkonen L; Vorimo S; Moilanen J; Winqvist R; Mantere T; Kuismin O; Pylkäs K
Fam Cancer; 2023 Jul; 22(3):291-294. PubMed ID: 36653541
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.
Yadav S; LaDuca H; Polley EC; Hu C; Niguidula N; Shimelis H; Lilyquist J; Na J; Lee KY; Gutierrez S; Yussuf A; Hart SN; Davis BT; Chao EC; Pesaran T; Goldgar DE; Dolinsky JS; Couch FJ
J Natl Cancer Inst; 2021 Oct; 113(10):1429-1433. PubMed ID: 33146377
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico.
Díaz-Velásquez CE; Gitler R; Antoniano A; Kershenovich Sefchovich R; De La Cruz-Montoya AH; Martínez-Gregorio H; Rojas-Jiménez EA; Cortez Cardoso Penha R; Terrazas LI; Wegman-Ostrosky T; Levi-Lahad E; Zabaleta J; Perdomo S; Vaca-Paniagua F
Front Genet; 2023; 14():1094260. PubMed ID: 36845387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
